Evidence map›Paper›PMID 31350122›Full record

ArticleThe Journal of adolescent health : official publication of the Society for Adolescent Medicine2019

Quantifying the Protective Effects of Stimulants on Functional Outcomes in Attention-Deficit/Hyperactivity Disorder: A Focus on Number Needed to Treat Statistic and Sex Effects.

Joseph Biederman, Maura DiSalvo, Ronna Fried, K Yvonne Woodworth, Itai Biederman, Stephen V Faraone

Open access · greenAbstract read
In one paragraph

Article in The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Joseph BiedermanClinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts. Electronic address: jbiederman@partners.org.
Maura DiSalvoClinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, Massachusetts.
Ronna FriedClinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
K Yvonne WoodworthClinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, Massachusetts.
Itai BiedermanClinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, Massachusetts.
Stephen V FaraoneDepartment of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, New York; K.G. Jebsen Centre for Psychiatric Disorders, Department of Biomedicine, University of Bergen, Bergen, Norway.
Massachusetts General Hospital · USHarvard University · USSUNY Upstate Medical University · US

Funding

OUTCOME OF ATTENTION DEFICIT HYPERACTIVITY DISORDERR01HD036317 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI BIEDERMAN, JOSEPH · 1998 to 2007
$4.0M
LONGITUDINAL FOLLOW UP OF ADHD GIRLS AND THEIR SIBLINGSR01MH050657 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI BIEDERMAN, JOSEPH · 1993 to 2002
$1.5M
NICHD NIH HHS R01 HD036317NIMH NIH HHS R01 MH050657
6 · The paper itself

Abstract

purposeThe aim of the study was to help quantify the protective effects of stimulant treatment on important functional outcomes in attention-deficit/hyperactivity disorder (ADHD) using the number needed to treat (NNT) statistic and examine whether these effects are moderated by sex.

methodsSubjects were derived from three independent samples, two similarly designed case-control, 10-year prospective follow-up studies of boys and girls with and without ADHD grown up and a cross-sectional randomized clinical trial of lisdexamfetamine on driving performance and behavior. For all studies, subjects were evaluated with structured diagnostic interviews. To measure psychopharmacologic treatment in the follow-up studies, we collected information about each subject's stimulant medication use, age at onset, and age at termination of treatment. Subjects in the driving study underwent two driving simulation assessments (premedication and after 6 weeks of treatment on lisdexamfetamine or placebo). For each outcome, we ran a logistic regression model that included an interaction between sex and treatment status. Lifetime rates were used to calculate the NNT statistic. We also calculated adjusted NNT statistics that accounted for sex, age, socioeconomic status, and family intactness.

resultsThe NNTs were very low, ranging from 3 to 10. No interaction effects with sex were detected (all p > .05). The adjusted NNTs mostly remained the same with the exception of any substance use disorder, which increased after controlling for age.

conclusionsStimulants have strong protective effects on functional outcomes in youth with ADHD that are not moderated by sex. These results support the critical importance of early identification and treatment of children with ADHD of both sexes.

Indexed as

AdolescentAttention Deficit Disorder with HyperactivityAutomobile Driver ExaminationCase-Control StudiesCentral Nervous System StimulantsCross-Sectional StudiesFemaleFollow-Up StudiesHumansLisdexamfetamine DimesylateMaleProspective StudiesRandomized Controlled Trials as TopicSex FactorsCentral Nervous System StimulantsLisdexamfetamine DimesylateADHDFunctional outcomesGenderProtective effectsStimulantsYouth

Identifiers

PMID31350122
PMCPMC6874726
OpenAlexW2963386304

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.